Author:
Mi Jia-Ning,Han Yuwei,Xu Yingqiong,Kou Junping,Wang Jing-Rong,Jiang Zhi-Hong
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Bondy, G. S. & Pestka, J. J. Immunomodulation by fungal toxins. J. Toxicol. Environ. Health B Crit. Rev. 3, 109–143 (2000).
2. Diesner, S. C. et al. Perspectives on immunomodulation early in life. Pediatr. Allergy Immunol. 23, 210–223 (2012).
3. Beckham, T. H., Cheng, J. C., Marrison, S. T., Norris, J. S. & Liu, X. Interdiction of sphingolipid metabolism to improve standard cancer therapies. Adv. Cancer Res. 117, 1–36 (2013).
4. Delgado, A., Fabriàs, G. Casas, J. & Abad, J. L. Natural products as platforms for the design of sphingolipid-related anticancer agents. Adv. Cancer Res. 117, 237–281 (2013).
5. The Pharmacopoeia Commission of PRC (Eds), Pharmacopoeia of the People’s Republic of China, Chemical Industry Publishing House, Beijing, pp. 36 (2010).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献